Furthermore, since HDAC6 histone deacetylase is required for HSF-1 activation [58], there is the prospect that Hsp90 inhibitors might act synergistically with HDAC inhibitors in promoting the growth arrest and apoptosis of tumour cells. Here, HSP90AB1 is linked to neoplasm.